StonvexLoading…
StonvexStonvexStonvexCore line items from SMWB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $282.60M | $249.91M | $218.02M | $193.23M |
Operating Income | $-23.56M | $-9.66M | $-28.81M | $-87.86M |
Net Income | $-32.94M | $-11.46M | $-29.37M | $-83.66M |
EPS (Diluted) | $-0.39 | $-0.14 | $-0.38 | $-1.10 |
Total Assets | $261.14M | $242.91M | $239.01M | $246.04M |
Total Liabilities | $237.82M | $215.40M | $223.47M | $224.09M |
Cash & Equivalents | $72.42M | $63.87M | $71.73M | $77.81M |
Free Cash Flow OCF − CapEx | $13.15M | $28.74M | $-4.60M | $-74.32M |
Shares Outstanding | 86.96M | 82.62M | 78.65M | 76.43M |